Newsletter Subject

Tech down again, these stocks not FAZEd

From

360wallstreet.io

Email Address

360wallstreet@mail.360wallstreet.io

Sent On

Mon, Sep 25, 2023 12:58 PM

Email Preheader Text

And live training today 11EST ?

And live training today 11EST                                                                                                                                                                                                                                                                                                                                                                                                                 Good morning! Here are our top investing ideas today – and complimentary training in Bullseye today at 11am EST. Ready more under Daily FOMO. Be the best prepared trader on the Street! BPTS - Up over 40% after signing partnership agreement with Skyepharma for the production of Sarceneos (BIO101) FAZE - Up over 70% in pre-market on no apparent news CYBN - Up 5% in pre-market after closing over 50% higher last week Now you, too, like these Miami Cheerleaders, can get [Jeff's pick of the week HERE]( before the market opens – [Image altered]( - hey ho, let’s go! And if you’re wondering how Jeff is planning for this week, he has a hunch the damage has been done and we’re headed lower. The bounces will be short-lived only to sucker in more buyers. However, he really doesn't care which way the markets are headed, the important thing is being on the right side of the trade. Jeff will be sharing his full game plan for the week in his live session TODAY (Monday) @ 11am EST (complimentary) in the [Shooting Gallery](. See you soon! BPTS - Up over 40% after signing partnership agreement with Skyepharma for the production of Sarceneos (BIO101) Biophytis S.A. (BPTS) is a clinical-stage biotechnology company that focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. This morning, [the company announced]( it had signed a partnership agreement with Skyepharma, a French pharmaceutical company, for the production of Sarceneos (BIO101) for severe forms of Covid-19, with a view to the submission of marketing authorization applications. BPTS had a market cap of just $4.24 million [according to Finviz]( based on yesterday’s close and a float of less than 2.4 million shares. The stock is up over 40% in pre-market on the news. The $1.17 area has acted as support so far in the pre-market and will be an important level to watch. Above it, targets to the upside are $1.30, and then the pre-market high of $1.48. Beyond that, $1.70, $2, $2.30, $2.50 and $3 come into play. Below $1.17, there is potential support at $1 and a gap fill at $0.8801. FAZE - Up over 70% in pre-market on no apparent news FaZe Holdings (FAZE) operates a lifestyle and media platform in gaming and youth culture. The company produces content, and designs merchandise and consumer products reaching approximately 528 million fans across social platforms. The stock made new all-time lows on Friday closing at $0.1530. This was a SPAC from 2022 that ran above $20 at one point. It is down over 95% since then. In July there were [reports from “sources”]( that FaZe Clan was eyeing two acquisition offers. [The Sports Business Journal said]( FAZE was evaluating offers from Gamesquare(GAME) and Enthusiast Gaming. Perhaps someone knows something here or maybe not, but the stock is in play this morning after finding some buyers in the after-hours on Friday. FAZE was trading over 70% higher in the pre-market. The $0.25/$0.24 area was resistance in the after-hours and now becomes potential support. Above it, targets to the upside are $0.28 and then the pre-market high of $0.2950. Beyond that, $0.40 and $0.50 come into play. Below $0.24, there is potential support at $0.22, $0.20 and then a gap to fill at $0.1530. CYBN - Up 5% in pre-market after closing over 50% higher last week Cybin Inc. (CYBN), a clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics. Last week CYBN was on traders’ radars after [it was disclosed]( that hedge fund owner Steve Cohen invested $19 million in the company. After the initial pop the stock held and continued higher on record volume despite significant weakness in the overall market and closed near the highs for the week. CYBN is one to keep on your watchlist for the possibility of more of the same this week. The $0.50 level was resistance last week and now becomes a potential area of support. Above it, the first target for bulls is last week's high of $0.58. Beyond that $0.70, $0.90 and $1 come into play. Below $0.50, there is potential support at $0.44, $0.40 and $0.38. [Economic Calendar]( DISCLAIMER: To more fully understand any Ragingbull. com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [(. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull. com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled. [tw]( Update your email preferences or unsubscribe [here]( © 2023 360wallstreet 62 Calef Hwy. #233 Lee, NH 03861, United States

Marketing emails from 360wallstreet.io

View More
Sent On

06/12/2024

Sent On

29/11/2024

Sent On

26/11/2024

Sent On

04/11/2024

Sent On

31/10/2024

Sent On

29/10/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.